Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102147452 | 10214745 | 2 | F | 2014 | 20160830 | 20140603 | 20160906 | EXP | US-ABBVIE-14P-163-1240408-00 | ABBVIE | 0.00 | M | Y | 150.73000 | KG | 20160906 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102147452 | 10214745 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 102147452 | 10214745 | 2 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 102147452 | 10214745 | 3 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 102147452 | 10214745 | 4 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 102147452 | 10214745 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 102147452 | 10214745 | 6 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 102147452 | 10214745 | 7 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 102147452 | 10214745 | 8 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 102147452 | 10214745 | 9 | C | NICOTINE. | NICOTINE | 1 | Transdermal | PATCH | 0 | ||||||||||
| 102147452 | 10214745 | 10 | C | MS CONTIN | MORPHINE SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102147452 | 10214745 | 1 | Psoriasis |
| 102147452 | 10214745 | 2 | Product used for unknown indication |
| 102147452 | 10214745 | 3 | Product used for unknown indication |
| 102147452 | 10214745 | 4 | Product used for unknown indication |
| 102147452 | 10214745 | 5 | Product used for unknown indication |
| 102147452 | 10214745 | 6 | Product used for unknown indication |
| 102147452 | 10214745 | 7 | Product used for unknown indication |
| 102147452 | 10214745 | 8 | Product used for unknown indication |
| 102147452 | 10214745 | 9 | Product used for unknown indication |
| 102147452 | 10214745 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102147452 | 10214745 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102147452 | 10214745 | Coronary artery occlusion | |
| 102147452 | 10214745 | Dry skin | |
| 102147452 | 10214745 | Oedema peripheral | |
| 102147452 | 10214745 | Pain in extremity | |
| 102147452 | 10214745 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102147452 | 10214745 | 1 | 2012 | 0 |